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Abstract
Background: Barriers to palliative care still exist in long-term care settings for older people, which can mean that
people with advanced dementia may not receive of adequate palliative care in the last days of their life; instead,
they may be exposed to aggressive and/or inappropriate treatments. The aim of this multicentre study was to
assess the clinical interventions and care at end of life in a cohort of nursing home (NH) residents with advanced
dementia in a large Italian region.
Methods: This retrospective study included a convenience sample of 29 NHs in the Lombardy Region. Data were
collected from the clinical records of 482 residents with advanced dementia, who had resided in the NH for at least
6 months before death, mainly focusing on the 7 days before death.
Results: Most residents (97.1%) died in the NH. In the 7 days before death, 20% were fed and hydrated by mouth,
and 13.4% were tube fed. A median of five, often inappropriate, drugs were prescribed. Fifty-seven percent of
residents had an acknowledgement of worsening condition recorded in their clinical records, a median of 4 days
before death.
Conclusions: Full implementation of palliative care was not achieved in our study, possibly due to insufficient
acknowledgement of the appropriateness of some drugs and interventions, and health professionals’ lack of
implementation of palliative interventions. Future studies should focus on how to improve care for NH residents.
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Background
Dementia is an incurable condition that causes a pro-
gressive decline in health, characterized by comorbidi-
ties, increased severity of physical and cognitive
disabilities, acute conditions typical of frailty, the wors-
ening of chronic comorbidities, and dementia-related
events such as recurrence of infections and eating prob-
lems, all of which require specific palliative care strat-
egies [1]. People with dementia can survive for years [2]
and are usually cared for in residential facilities, in par-
ticular in nursing homes (NHs), which provide many or
all of the long-term care services they need until their
death [3]. Thus, for most of their residents, NHs should
be prepared and able to provide palliative care.
However, barriers to palliative care still exist in long-
term care settings for older people [4], which can mean
that people with advanced dementia may not receive ad-
equate palliative care in the last days of their life; instead
they may be exposed to aggressive and/or inappropriate
treatments [5–7]. Lack of communication between
health care professionals and family carers is a barrier to
the implementation of palliative care as family carers
may be reluctant to accept that their relative is in the
dying phase [1]. However, the family’s understanding of
the disease progression and of the dying phase does not
always guarantee the implementation of palliative care
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[8]. Other barriers are high staff turnover (especially
nurses) [9]; limited number of nurses [10]; and lack
of competence in palliative care [11, 12]. Important
differences in palliative care delivery do exist across
countries [13], and also among institutions within the
same country [14]. Italian NHs differ widely in the
number of beds they have, the services they offer, and
their quality of care, but very few provide palliative
care consultations [6, 15].
Methods
Aim
The aim of this multicentre study was to assess the clin-
ical interventions and care at end of life in a cohort of
NH residents with advanced dementia in a large Italian
region.
Study setting
We used data from the Valuazione dell’Efficacia della
Leniterapia nell’Alzheimer e Demenze (VELA Project)
[16], which was conducted in collaboration with the
Fondazione Italiana Leniterapia of Florence and the Lino
Maestroni Palliative Medicine Research Foundation of
Cremona. The aim of the VELA Project was to compare
end-of-life care procedures provided to NH residents
with advanced dementia in the Lombardy Region, and in
the surrounding areas of Florence in the Tuscany
Region, before and after a short educational intervention
to improve palliative care. Due to regional differences in
the organization of NHs and in the services provided to
NH residents with dementia, here we present only data
from the Lombardy Region.
In the Lombardy Region, accredited NHs have their
own medical and nursing staff, with a regulatory require-
ment ratio of ≥901 min/week of care per resident [17];
these NHs may be defined as “skilled NHs”. With few
exceptions, there is at least one nurse with a bachelor’s
degree available per shift. NHs in the region may also
rely on consultants (geriatricians, neurologists, physiat-
rists, etc.) and may employ psychologists, occupational
therapists, physiotherapists, or other specialists. Out of a
network of 34 NHs in the Lombardy Region that partici-
pated in a previous study [15], 29 agreed to participate
in the present study (number of beds per NH ranged
from 40 to 714). To be included in the analysis, NH resi-
dents had to have a Functional Assessment Staging Tool
(FAST) stage ≥7c (double incontinence; loss of all intelli-
gible vocabulary; non-ambulatory) [18] and have resided
in the NH for at least 6 months before death.
The study was approved by the ethics committee of
Don Carlo Gnocchi Foundation of Milano on February
20, 2013; it started on April 1, 2013 and concluded on
January 31, 2015. In this paper, we describe the 60 days
before death, with a special focus on the last 7 days in
the entire cohort (pre and post educational intervention)
of NH residents. Due to the limited impact of the educa-
tional intervention [16], the two cohorts were merged.
Data collection
Trained monitors collected data from clinical records,
nursing records, and drug data sheets on up to 20 resi-
dents in each of the 29 participating NHs. This informa-
tion included demographic characteristics, major
comorbidities, and cause of death, as well as presence of
the following: a comprehensive evaluation of the severity
of clinical conditions, advance care planning, a legal rep-
resentative (guardian), do not resuscitate (DNR) and do
not hospitalize (DNH) orders, NH resident’s wishes
about treatment and funeral dispositions, and any other
advance directive (AD). Specific information was also
collected on nutrition and hydration in the 60 and 7 days
before death, as well as on dialysis, symptoms, tests and
interventions administered such as endotracheal suction-
ing, hospitalizations and admissions to the emergency
department, assessment of pain and discomfort, drugs
prescribed (classified according to the Anatomical
Therapeutic Chemical code) [19], and palliative sedation
in the 7 days before death. Nutrition and hydration were
classified by a panel of experts (including experts in pal-
liative care, geriatrics, nursing, psychology, family medi-
cine, and bioethics) as palliative-oriented nutrition if
nutrition and/or hydration were given by mouth only, if
nutrition by mouth was accompanied by comfort hydra-
tion (i.e. the administration of < 1000ml of fluids/day by
subcutaneous hydration), if only subcutaneous hydration
was used, or if no nutrition or hydration was provided at
all [16]. Comfort hydration was seen as a compromise
between the advisability to reduce water intake to im-
prove comfort and reduce symptoms, and family mem-
bers’ expectations and beliefs about hydration [20].
Nutrition and hydration were classified as non-palliative-
oriented nutrition if given by parenteral route, via naso-
gastric tube, or via percutaneous endoscopic gastrostomy
at any point during the 7 days before death [16]. Drugs
prescribed in the 7 days before death were collected
from drug sheets. NH residents with missing drug sheets
and those who were admitted to hospital or the emer-
gency department in the 7 days before death were ex-
cluded from the analyses on drugs prescribed.
Statistical analyses
For categorical variables, data are shown as absolute and
relative (%) frequencies with 95% confidence intervals
(CIs). Mean and standard deviation or median and inter-
quartile range (IQR), as appropriate, were calculated for
continuous variables. All analyses were performed with
Stata 14 (StataCorp., College Station, TX, USA).
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Results
A cohort of 482 NH residents was recruited, 26.8% of
whom had Alzheimer-type dementia. Overall, half of the
residents had between five and eight comorbidities (me-
dian 6), and 25% had more than eight comorbidities
(Table 1).
Almost all residents (468, 97.1%) died in the NHs (me-
dian age at death: 89 years, IQR 83.6–93.1), 69 (14.7%)
of them had a family member present during the last
hours of life (this information was available for 358 resi-
dents). Cause of death was available for 374 (77.6%) NH
residents, 96 (25.7%) of whom had dementia reported as
the cause of death. Only one NH resident had a self-
written AD; in 19 (3.9%) cases, a family member
reported the NH resident’s wishes; and 60 (12.4%) resi-
dents had guardian. In six (1.2%) cases, the family re-
ported the resident’s preference for cremation.
In the 60 days before death, 378 (78.4%) NH residents
were fed only by mouth; 43 (8.9%) were fed by mouth
and intravenous or subcutaneous integration; and 43
(8.9%) were tube fed; data where missing for the
remaining 18 residents. During the 60 days before death,
a new feeding tube was placed in 26 NH residents (of
the 63 with a feeding tube in the 7 days before death, 37
already had it at 60 days before death).
7 days before death
A substantial worsening of clinical conditions (some-
times defined as “terminal conditions”) was recorded in
the clinical records a median of 4 days (IQR 2–11) be-
fore death for 275 (57.1%) NH residents, and the notifi-
cation of impending death was recorded a median of 1
day before death (IQR 0–3) for 150 (31.1%) residents.
Advance care planning was drawn up for only 21 NH
residents (4.4%) (median 15 days before death; IQR 5–
41). Two (0.4%) NH residents had a DNR, seven had a
DNH (1.5%), and one NH resident had both.
Two hundred and nine residents’ clinical records in-
cluded a registration of discussions with families on the
worsening of residents’ conditions, which took place a
median of 3 (IQR 1–7) days before death. Eighty-six of
these records also reported a discussion with the family
of decisions to be made, which took place a median of 6
(IQR 2–20) days before death.
After the exclusion of 13 NH residents with missing
information on nutrition and hydration, we observed
Table 1 Main characteristics of the 482 nursing home (NH) residents with advanced dementia (Functional Assessment Staging Tool
stage ≥7c)
n (n = 482) % 95% CIb (%)
Sex Female 365 75.7 71.9;79.5
Age at NH admission, years, median (IQRb): 84.1 (79–88.7)
Diagnosis of dementia
Alzheimer 129 26.8 22.8;30.7
Not defined 175 36.3 32.0;40.6
Vascular 138 28.6 24.6;32.7
Mixed 33 6.8 4.6;9.1
Lewy body 7 1.5 0.4;2.5
Comorbidities
Genitourinary 435 90.2 87.6;92.9
Musculoskeletal 409 84.9 81.6;88.0
Gastrointestinal tract 135 28.0 24.0;32.0
Peripheral and central nervous system 314 65.1 60.9;69.4
Hypertension 238 49.4 44.9;53.8
Cardiovascular 237 49.2 44.7;53.6
Head and neck 207 42.9 38.5;47.4
Vascular 195 40.5 36.1;44.8
Respiratory 100 20.7 17.2;24.4
Endocrine-metabolic 135 28.0 24.0;32.0
Kidney 55 11.4 8.6;14.2
Liver 30 6.2 4.1;8.4
Othersa 18 3.7 2.0;5.4
aOthers: other cancers [15]; anemia [2]; pressure sores [1]
bCI Confidence interval, IQR Interquartile range
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palliative-oriented nutrition in 130 (27.7%) residents
(Table 2).
Overall, 101 NH residents (21%) received at least one
invasive treatment or intervention in the 7 days before
death (Table 3).
In the 7 days before death, nine residents were sent to
the emergency department and then discharged, while
14 were admitted to hospital (2.9%). Pain and/or dis-
comfort were assessed for 192 (39.8%) residents. In 13
(2.7%) cases, palliative pharmacological sedation was
provided; 70 residents (14.5%) underwent resuscitation
attempts, 62 of which were performed by NH staff: five
as cardio-pulmonary resuscitation, and 66 with life-
saving drugs.
Data on drugs prescribed were available for 316
(65.6%) NH residents; a median of five (IQR 3–7) drugs
were prescribed for these residents in the 7 days before
death, and 22.2% NH residents had two or fewer drugs
prescribed (Table 4).
Discussion
This study presents data on a large cohort of NH resi-
dents with advanced dementia who died in a NH located
in a large region of northern Italy. In contrast to previ-
ous studies, in which one-third of NH residents were
hospitalized in the last month of life and the rate of
death in hospital was almost 66% [21, 22], the vast ma-
jority of our residents died in the NHs: only 4.7% of
them were admitted to hospital or sent to the emergency
department. This low figure may be considered positive,
as hospitalization can be aggressive and of limited clin-
ical benefit for people with advanced dementia [23]. The
availability of a full-time physician, and the fact that all
NHs that participated in the present analysis are skilled
NHs, may account for this result.
In general, although the care received by NH residents
with advanced dementia in the 7 days before death
showed room for improvement, it also showed a prefer-
ence for non-aggressive treatment. Sixty days before
death, the vast majority of NH residents (78.4%) were
fed only by mouth, but, as expected, that number de-
creased to nearly one in five (20%) in the 7 days before
death. Overall, one-third of NH residents received
palliative-oriented nutrition in the 7 days before death. It
is broadly acknowledged that tube feeding in people with
advanced dementia is ineffective and even harmful, and
that possible symptoms of dehydration can be effectively
treated with small amounts of fluids (by mouth or by
subcutaneous fluids administration) with good oral care
[24]. Nevertheless, relatives often ask for substantial nu-
trition and hydration [25]. The limited use of subcutane-
ous fluids administration in our study could be ascribed
to a lack of knowledge of this technique on the part of
NH staff [26].
The figures we report related to feeding tubes, namely
the number of patients who died with a feeding tube in
place, are higher than those reported in a Dutch [27]
and a US study, which showed a decrease in tube feeding
over 15 years (from 11.7% in 2000 to 5.7% in 2014) [28].
Nevertheless, our results reflect a substantial positive
trend when compared with the findings of a previous
study (tube feeding 21.0% vs tube feeding and parenteral
nutrition 16.6%; intravenous hydration 66% vs 48.4%)
carried out in 2005 in a smaller sample of NHs in the
same region [5]. The same trend toward a less aggressive
approach was shown by the decreased use of intravenous
fluid administration (from 67% to nearly 40%) [6]. Fur-
ther positive findings from our study concern the use of
drugs, with the increased use of opioids (from 4.9% at
baseline [29] to 34.2% in the 7 days before death) and
acetaminophen (from 4.5% [29] to 7.6%); the low rate of
blood samples taken (less than 2 patients out of 10); and
the low rate of other invasive treatments/interventions.
Some aspects still require closer scrutiny and improve-
ment, in particular clinical factors. For example, the pre-
scribing of inappropriate drugs [30, 31], such as
anticoagulants/antiplatelets and anti-arrhythmics classes
I-III, continued in our study. Moreover, diuretics, beta-
blocking agents, antipsychotics, and antibiotics, even if
considered “sometimes appropriate”, seemed to be
overly prescribed in the last 7 days before death (hyos-
cine, steroids, and antacids may have been prescribed as
symptomatics). There was also an overuse of procedures
like intravenous catheter placement and an underuse of
subcutaneous fluids administration.
The acknowledgement of the worsening of resident’s
conditions was reported in the clinical records of 57% of
NH residents a few days before death (median 4), but
only 21 of these residents had a care plan in place.
Lastly, considering the residents’ advanced stage of de-
mentia, some questionable resuscitation attempts were
carried out (14.5%, mostly with drugs). The trajectories
of decline in persons with dementia are uncertain [32];
therefore it is not easy to assess when a resident is ap-
proaching death. If the proximity of death is only ac-
knowledged when a resident’s health condition rapidly
Table 2 Nutrition and hydration in the 7 days before death
n (n = 469)b % 95% CIa (%)
IVa hydration (alone or supplement) 227 48.4 43.9;52.9
Nutrition/hydration by mouth only 94 20.0 16.4;23.7
SFAa only (or SFA+ mouth) 70 14.9 11.7;18.1
Tube feeding 63 13.4 10.3;16.5
Parenteral Nutrition 15 3.2 1.6;4.8
Comfort hydration (IV and SFA) 99/455 21.8 18.0;25.5
aCI Confidence interval, IV Intravenous, SFA Subcutaneous fluids administration
b13 residents with missing information on nutrition and hydration
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declines [33], fewer opportunities are left to provide
palliative care and hospice referral [34]. The difficulty
of defining terminality, and of reliably estimating sur-
vival in people with advanced dementia requires
structured investments to produce effective tools to
identify and evaluate these factors [35]. These findings
also show the need to improve the knowledge of NH
staff, including physicians, on these issues [16]. This
need is reflected in the urgency placed on national
regulatory bodies and international scientific boards
to produce up-to-date, widely accepted guidelines on
the appropriate pharmacological approach to take in
patients with dementia who are at the end of their
life [7, 30].
Table 3 Invasive treatments/interventions in the 7 days before death
n (n = 482) % 95% CIb (%)
Oral/tracheal suctioning 101 21.0 17.3;24.6
Blood collection 73 15.1 11.9;18.3
Peripheral vein cannulation (one or more attempts) 53 11.0 8.2;13.8
Insertion/repositioning of urinary catheter 30 6.2 4.1;8.4
Insertion/repositioning of a nasogastric tube (2 PEGsb) 11 2.3 0.9;3.6
Insertion of a central venous catheter 3 0.6 0.0;1.3
Other invasive treatmentsa 6 1.2 0.2;2.2
aOther treatments (residents could be exposed to more than one treatment): Enema [2]; Glycaemia measurement [2]; Hemogasanalysis [1]; Flu vaccine [1]
bCI Confidence interval, PEG Percutaneous endoscopic gastrostomy
Table 4 Prescriptions in the 7 days before death classified according to the Anatomical Therapeutic Chemical (ATC) code
ATC code n (n = 316) % 95% CIb (%)
Anticoagulants - Antiplatelets B01A 166 52.5 47.0;58.0
Drugs for acid related disorders A02 153 48.4 42.9;53.9
Cardiovascular System C
Cardiac therapy C01A, C01D 130 41.1 35.7;46.6
Beta blocking agents C07 31 9.8 6.5;13.1
Anti-arrhythmic class I-III C01B 8 2.5 0.8;4.2
Antibiotics (antibacterial/antimycotics) J01;J02 107 33.9 28.6;39.1
Diuretics C03 110 34.8 29.5;40.1
Opioids N02A 108 34.2 28.9;39.4
Laxatives A06 96 30.4 25.3;35.4
Vitamins and mineral supplements A11; A12 88 27.8 22.9;32.8
Antipsychotics N05A 79 25.0 20.2;29.8
Benzodiazepine derivates N05CD 70 22.2 17.6;26.7
Steroids H02AB 58 18.4 14.1;22.6
Drugs for the respiratory system R 37 11.7 8.2;15.2
Antiepileptics N03 30 9.5 6.3;12.7
Insulin and other glucose lowering A10 27 8.5 5.5;11.6
Acetaminophen N02B 24 7.6 4.7;10.5
Antidepressants N06 24 7.6 4.7;10.5
Anti-parkinson N04 23 7.3 4.4;10.1
Antiemetics A04 19 6.0 3.4;8.6
Hyoscine Butylbromide N07 14 4.4 2.2;6.7
Thyroid drugs H03 17 5.4 2.9;7.9
Othersa 29 9.2 6.0;12.4
aOthers: Allopurinol (M04 11), Drugs for benign prostatic hypertrophy (Tamlusosin, Finasteride (G04 AC, 10), Antidiarrhoics (A07, 5), Ursodesooxyicholic acid
(A05AA02 4), Drugs for treatment of hyperkaliemia and hyperphosphatemia (V03AE, 3), Hormone antagonists (L02, 2), Baclofen (M03BX, 2); only 1: Epoietine (B03);
Rociverine (A03AA)
bCI Confidence interval
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Critical decisions also require closer scrutiny and im-
provement. One of the most disappointing findings was
the extremely low presence of ADs, whether they were
self-written or communicated by relatives, and the scar-
city of guardians and/or surrogates. In Italy, the legal
representative must be appointed by a magistrate, gener-
ally at the request of the health care provider (e.g., gen-
eral practitioner and/or the NH doctor), and this
procedure can take some time. This may explain the
scarcity of DNR and/or DNH orders in our study (over-
all 8 NH residents) and even the use of palliative
pharmacological sedation. DNR and DNH orders are far
more common in other European countries: 2.4% in our
study, compared to 21.0% in Holland [36] and 60% in
the US [37].
Family involvement in decisions was documented in
only 86 clinical records, and a recent study reported
that most decisions are first taken by the physicians
and only later communicated to relatives [15]. The
low prevalence of advance care planning suggests a
tendency to avoid addressing the issue with family
[38], and efforts should be made to improve this.
Advance care planning implies the involvement of
family, in what have been called “expectation conver-
sations” [39]. Only 3.4% of NH residents were in-
volved in conversations on desired end-of-life care in
the van der Voot et al. study [36] (although more
than 60% were cognitively competent at admission),
and even if NH staff say they are available to speak
with NH residents’ relatives about death and dying
when they are “terminal” [38], systematic, periodic
conversations with families are a crucial instrument
to reducing NH staff’s uncertainty in clinical decision-
making and to improve the family’s perceptions of
quality of care in NHs [39, 40].
Critical decisions may affect the time of death, the
place of death [33], and the way a person will live her/
his last days. If a patient is incapacitated and there is no
surrogate and/or ADs, the ultimate responsibility for
treatment decisions falls on the physician, whose deci-
sions may be affected by several factors, such as the con-
text (setting and culture) [41], personal and societal
values and constraints, and medical training that is
overly focused on curing [15, 42]. A framework that
shares this planning with the family may reduce the
temptation to revert to the use of defensive medicine
(i.e., practices undertaken primarily to avoid liability ra-
ther than to benefit the patient), which may be partially
responsible for resuscitation attempts, placement of
feeding tubes [25], the drawing of blood samples, the
avoidance of writing DNR/DNH orders, etc. This behav-
ior implies that, in spite of the spread and seeming ac-
ceptance of the principles and methods of palliative care,
at least in NHs, prejudices and fears persist.
Our results are limited by the retrospective nature of
the study and by data retrieval from clinical records;
some aspects such as relatives’ involvement in decisions
may have been under-reported. Although this is a multi-
centre study, each NH contributed the same number of
cases, thus limiting the possible over-representation of
residents from larger NHs. Data were collected by ex-
pert, trained researchers, which may have limited inter-
pretation problems.
Conclusions
Notwithstanding some clear improvements in the quality
of palliative care, which reflects a positive trend toward a
less aggressive approach to treatment among NH resi-
dents with advanced dementia in their last days of life,
there are still some barriers to a full implementation of
palliative care. In particular, insufficient acknowledge-
ment of the inappropriateness of some drugs and inter-
ventions, and reluctance to implement end-of-life
palliative care interventions. In order to provide quality
palliative care to NH residents with advanced dementia,
up-to-date, widely accepted guidelines on the pharmaco-
logical approach to take in patients with advanced de-
mentia are urgently needed. At the same time, changes
in the cultural approach to death and dying are neces-
sary in NH staff and the general population if clinically
correct care strategies are to be outlined that can be
agreed upon by NH residents and their families.
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